SGHT insider buying and SEC filings, explained
Sight Sciences, Inc. · CIK 1531177
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$185K
Insiders who bought
1
Sold (not marked 10b5-1)
$674K
Planned sales (10b5-1)
$2.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 2, 2026 | Planned (10b5-1) | Brenton Taylor (EVP, Operations & R&D) sold 2,988 shares at about $8.85 ($26K), marked as a 10b5-1 plan trade. Holdings down 1% to 261,990 shares. | SEC filing Filed Oct 5, 2026, 4:43 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | Alison Bauerlein (President / COO) sold 25,260 shares at about $8.85 ($224K), marked as a 10b5-1 plan trade. Holdings down 4% to 639,449 shares. | SEC filing Filed Oct 5, 2026, 4:43 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | James Rodberg (CFO) sold 7,208 shares at about $8.85 ($64K), marked as a 10b5-1 plan trade. Holdings down 3% to 216,829 shares. | SEC filing Filed Oct 5, 2026, 4:42 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | David Badawi (Chief Technology Officer and Director) sold 7,797 shares at about $9.05 ($71K), marked as a 10b5-1 plan trade. Holdings down <1% to 1,975,075 shares. | SEC filing Filed Oct 5, 2026, 4:40 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Paul Badawi (CEO and Director) sold 29,653 shares at about $9.05 ($268K), marked as a 10b5-1 plan trade. Holdings down <1% to 6,092,819 shares. | SEC filing Filed Oct 5, 2026, 4:40 PM ET |
| Jul 6, 2026 | Planned (10b5-1) | Jeremy B. Hayden (Chief Legal Officer) sold 12,733 shares at about $5.51 ($70K), marked as a 10b5-1 plan trade. Holdings down 3% to 357,037 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | David Badawi (Chief Technology Officer and Director) sold 7,418 shares at about $5.51 ($41K), marked as a 10b5-1 plan trade. Holdings down <1% to 1,982,872 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | James Rodberg (CFO) sold 6,902 shares at about $5.36 ($37K), marked as a 10b5-1 plan trade. Holdings down 3% to 224,037 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Alison Bauerlein (President / COO) sold 24,184 shares at about $5.36 ($130K), marked as a 10b5-1 plan trade. Holdings down 4% to 664,709 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Brenton Taylor (EVP, Operations & R&D) sold 2,829 shares at about $5.42 ($15K), marked as a 10b5-1 plan trade. Holdings down 1% to 264,978 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Paul Badawi (CEO and Director) sold 28,684 shares at about $5.42 ($155K), marked as a 10b5-1 plan trade. Holdings down <1% to 6,122,472 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 10, 2026 | Purchase (code P) | Staffan Encrantz (Director and 10% owner) bought 14,100 shares at about $4.88 ($69K), reported as a purchase (code P). Holdings up 1% to 1,434,283 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 11, 2026 |
| May 18, 2026 | Planned (10b5-1) | Alison Bauerlein (President / COO) sold 12,728 shares at about $5.12 ($65K), marked as a 10b5-1 plan trade. Holdings down 2% to 688,893 shares. | SEC filing Filed May 19, 2026 |
| Apr 6, 2026 | Planned (10b5-1) | James Rodberg (CFO) sold 7,231 shares at about $3.55 ($26K), marked as a 10b5-1 plan trade. Holdings down 3% to 230,939 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 6, 2026 | Planned (10b5-1) | Jeremy B. Hayden (Chief Legal Officer) sold 13,761 shares at about $3.55 ($49K), marked as a 10b5-1 plan trade. Holdings down 4% to 369,770 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 2, 2026 | Planned (10b5-1) | Alison Bauerlein (President / COO) sold 25,874 shares at about $3.48 ($90K), marked as a 10b5-1 plan trade. Holdings down 4% to 701,621 shares. | SEC filing Filed Apr 3, 2026 |
| Apr 2, 2026 | Planned (10b5-1) | David Badawi (Chief Technology Officer and Director) sold 8,168 shares at about $3.48 ($28K), marked as a 10b5-1 plan trade. Holdings down <1% to 1,990,290 shares. | SEC filing Filed Apr 3, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Brenton Taylor (EVP, Operations & R&D) sold 2,869 shares at about $3.70 ($11K), marked as a 10b5-1 plan trade. Holdings down 1% to 267,807 shares. | SEC filing Filed Apr 3, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Paul Badawi (CEO and Director) sold 29,244 shares at about $3.70 ($108K), marked as a 10b5-1 plan trade. Holdings down <1% to 6,151,156 shares. | SEC filing Filed Apr 3, 2026 |
| Jan 16, 2026 | Planned (10b5-1) | David Badawi (Chief Technology Officer and Director) sold 4,836 shares at about $6.62 ($32K), marked as a 10b5-1 plan trade. Holdings down <1% to 1,912,273 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 16, 2026 | Planned (10b5-1) | James Rodberg (CFO) sold 2,616 shares at about $6.62 ($17K), marked as a 10b5-1 plan trade. Holdings down 2% to 151,230 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 16, 2026 | Planned (10b5-1) | Paul Badawi (CEO and Director) sold 22,362 shares at about $6.62 ($148K), marked as a 10b5-1 plan trade. Holdings down <1% to 6,025,840 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 16, 2026 | Planned (10b5-1) | Jeremy B. Hayden (Chief Legal Officer) sold 6,308 shares at about $6.62 ($42K), marked as a 10b5-1 plan trade. Holdings down 2% to 267,611 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 6, 2026 | Sale | Brenton Taylor (EVP, Operations & R&D) sold 619 shares at about $7.48 ($5K). Holdings down <1% to 170,212 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 5–6, 2026 | Planned (10b5-1) | Jeremy B. Hayden (Chief Legal Officer) sold 11,170 shares between Jan 5 and Jan 6 at about $7.77 ($87K), marked as a 10b5-1 plan trade. Holdings down 4% to 245,420 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 5–6, 2026 | Sale | James Rodberg (CFO) sold 4,999 shares between Jan 5 and Jan 6 at about $7.78 ($39K). Holdings down 3% to 153,846 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 5–6, 2026 | Sale | Alison Bauerlein (President / COO) sold 20,543 shares between Jan 5 and Jan 6 at about $7.66 ($157K). Holdings down 3% to 599,983 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 2–6, 2026 | Sale | Paul Badawi (CEO and Director) sold 37,226 shares between Jan 2 and Jan 6 at about $7.45 ($277K). Holdings down 1% to 5,925,276 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 2–6, 2026 | Sale | David Badawi (Chief Technology Officer and Director) sold 9,660 shares between Jan 2 and Jan 6 at about $7.57 ($73K). Holdings down 1% to 1,917,109 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Dec 16, 2025 | Purchase (code P) | Staffan Encrantz (Director and 10% owner) bought 13,958 shares at about $8.31 ($116K), reported as a purchase (code P). Holdings up 1% to 1,391,922 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 2, 2025 | Sale | James Rodberg (CFO) sold 2,518 shares at about $8.25 ($21K). Holdings down 2% to 158,845 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
| Nov 25, 2025 | Planned (10b5-1) | Jeremy B. Hayden (Chief Legal Officer) sold 44,850 shares at about $8.08 ($362K), marked as a 10b5-1 plan trade. Holdings down 15% to 256,590 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 17, 2025 | Sale | Brenton Taylor (EVP, Operations & R&D) sold 14,418 shares at about $7.06 ($102K). Holdings down 8% to 170,831 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
| Nov 12, 2025 | Planned (10b5-1) | Jeremy B. Hayden (Chief Legal Officer) sold 3,150 shares at about $8.01 ($25K), marked as a 10b5-1 plan trade. Holdings down 1% to 256,590 shares. | SEC filing Filed Nov 14, 2025 |
19 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SGHT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.